NCT05795881

Brief Summary

Disruption of circadian rhythms is frequently observed in patients in the intensive care unit (ICU) and is associated with worse clinical outcomes. The ICU environment presents weak and conflicting timing cues to the circadian clock, including continuous enteral nutrition. The goal of this clinical trial is to evaluate the effect of timing of enteral nutrition on the circadian rhythm in critically ill patients. Patients admitted to the intensive care unit will be allocated to receive either continuous or cyclic daytime (8am to 8 pm) enteral feeding. Differences in circadian rhythms will be assessed by 24h patterns in core body temperature, heart rate variability, melatonin and peripheral clock gene expression. Secondary outcomes include depth of sleep, glucose variability and incidence of feeding intolerance. This study is expected to contribute to the optimalisation of circadian rhythms in the ICU.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 6, 2023

Completed
28 days until next milestone

First Posted

Study publicly available on registry

April 3, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

June 14, 2023

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2025

Completed
Last Updated

March 20, 2025

Status Verified

March 1, 2025

Enrollment Period

1.8 years

First QC Date

March 6, 2023

Last Update Submit

March 18, 2025

Conditions

Keywords

Randomized Controlled Trial

Outcome Measures

Primary Outcomes (2)

  • Amplitude of 24-h rhythm of core body temperature

    Determined by cosinor analysis

    Day 3 (8 a.m.) to day 4 (8 a.m.) after start of the study intervention (= start of enteral nutrition)

  • Acrophase 24-h rhythm of core body temperature

    Determined by cosinor analysis

    Day 3 (8 a.m.) to day 4 (8 a.m.) after start of the study intervention (= start of enteral nutrition)

Secondary Outcomes (18)

  • Amplitude of 24-h rhythm of plasma melatonin levels

    Day 3 (8 a.m.) to day 4 (8 a.m.) after start of the study intervention (= start of enteral nutrition)

  • Acrophase of 24-h rhythm of plasma melatonin levels

    Day 3 (8 a.m.) to day 4 (8 a.m.) after start of the study intervention (= start of enteral nutrition)

  • Amplitude of 24-h rhythm in heart rate variability

    Day 3 (8 a.m.) to day 4 (8 a.m.) after start of the study intervention (= start of enteral nutrition)

  • Acrophase of 24-h rhythm in heart rate variability

    Day 3 (8 a.m.) to day 4 (8 a.m.) after start of the study intervention (= start of enteral nutrition)

  • Amplitude of 24-h rhythm in systolic blood pressure

    Day 3 (8 a.m.) to day 4 (8 a.m.) after start of the study intervention (= start of enteral nutrition)

  • +13 more secondary outcomes

Study Arms (2)

Control group

NO INTERVENTION

continuous enteral nutrition: 24 hours a day (standard of care)

Intervention group

EXPERIMENTAL

cyclic daytime enteral nutrition: between 8 a.m. and 8 p.m. (same amount of nutrition as control group)

Other: Cyclic daytime enteral nutrition

Interventions

The allocated feeding schedule is followed from the start of enteral nutrition after ICU admission until discharge from the ICU.

Intervention group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years old
  • Receiving of or intention to start enteral nutrition via nasogastric or nasoduodenal tube
  • Arterial line
  • Expected duration of ICU admission \> 48 hours

You may not qualify if:

  • Receiving parenteral nutrition
  • Chronic enteral tube feeding prior to current admission
  • Presence of one or more contraindications of enteral feeding and/or at significant risk for gastrointestinal tolerance according to standard protocol (including but not limited to gastrointestinal haemorrhage, intestinal ischemia or necrosis, impaired digestive tract integrity due to obstruction or perforation, gastrectomy, enterectomy, history of gastroparesis or oesophageal dysmotility or expected surgery within 24 hours)
  • Patients with glycaemic emergency (including but not limited to hyperglycaemic hyperosmolar nonketotic coma, diabetic ketoacidosis, severe hypoglycaemia resulting in ICU admission) or patients controlling their glucose levels and insulin dosing via continuous glucose monitoring
  • Expected death within 24 hours
  • Do-not-resuscitate (DNR) order
  • Treatment with extracorporeal membrane oxygenation
  • Severe neurological damage (significant neurological abnormalities such as bleeding, ischemia, neurotrauma or severe encephalopathy with Glasgow Coma Scale ≤ 8)
  • Suspected or confirmed pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Leiden University Medical Center

Leiden, 2333ZA, Netherlands

Location

Related Publications (2)

  • Kouw IWK, Heilbronn LK, van Zanten ARH. Intermittent feeding and circadian rhythm in critical illness. Curr Opin Crit Care. 2022 Aug 1;28(4):381-388. doi: 10.1097/MCC.0000000000000960. Epub 2022 Jul 5.

    PMID: 35797531BACKGROUND
  • Hiemstra FW, van Gent MF, de Jonge E, van Westerloo DJ, Kervezee L. Effect of cyclic daytime versus continuous enteral nutrition on circadian rhythms in critical illness (CIRCLES): Study protocol for a randomized controlled trial. Contemp Clin Trials. 2025 Jul;154:107927. doi: 10.1016/j.cct.2025.107927. Epub 2025 Apr 27.

MeSH Terms

Conditions

Critical Illness

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • David J van Westerloo, PhD, MD

    Leiden University Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Investigator-Initiated Randomized Controlled Trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD PhD

Study Record Dates

First Submitted

March 6, 2023

First Posted

April 3, 2023

Study Start

June 14, 2023

Primary Completion

March 15, 2025

Study Completion

March 15, 2025

Last Updated

March 20, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will share

Immediately following publication, the individual participant data that underlie the results reported in the published article will be shared after deidentificiation. The data will be shared upon request with researchers who wish to access the data for any purpose.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
The data will be available immediately following publication.
Access Criteria
to be announced

Locations